CD300E and plasma cell myeloma: The Human Atlas database further assessed the protein expression of CD300E across various cancers, showing upregulation in Myeloma, Diffuse large B-cell lymphoma, Ovarian cancer, Lung cancer, and Colorectal cancer without significant downregulation in any cancer type (Figure 2C).